IVI will convene a series of webinars in 2021 to communicate research findings, explore new methodologies in value assessment, and host public dialogue on relevant issues. Join IVI for open conversations about best practices with researchers, patient organizations, policymakers, and those who pay for care.

Below are upcoming and recent IVI webinars. To view past events, visit our webinar archive here.

Featured Events

There is widespread acknowledgement that the data inputs supporting value and health technology assessment are insufficient, both in their lack of representative diversity and their failure to capture real-world factors that matter to communities living with chronic health conditions.

IVI will host a three-part webinar series to frame discussions about improving equity in research: representing patient community perspectives in the methods that support value assessment and developing policy solutions to support such initiatives. This series will build toward IVI’s second annual Methods Summit in late 2021, where both gaps and emerging approaches in improving patient-centered data inputs to research and value assessment will be examined. The three webinars will focus on identifying areas of consensus and current initiatives, as well as essential actions to propel lasting, durable change.

Session 1

Meaningful Action Toward Health Equity

Thursday, April 22, 2021

1:00 PM – 2:15 PM EDT

View Webinar

Session 2

Methods in Value Assessment that Support Equity

Thursday, June 24, 2021

2:00 PM – 3:15 PM EDT

View Webinar

Session 3

Walking the Talk – How Should Policy Uphold Equity in Value Assessment?

WEDNESDAY, JULY 14, 2021

1:00 PM – 2:15 PM EDT

View Webinar

After participating in this series, participants will be able to:

  • Define and discuss equity issues in the context of value assessment.

  • Consider challenges and solutions in improving representativeness in research.

  • Evaluate existing and emerging methods that support equity in value assessment.

  • Identify policy solutions at all levels that can support improvement in research equity.

Who should attend:

  • Health economics and outcomes researchers

  • Patient, family, and disease community researchers and advocates
  • Innovators from pharmaceutical, device, digital, and other healthcare industries

  • Employers

  • Insurers, pharmacy benefit managers, benefits consultants, pathway developers

  • Policymakers

Upcoming Events

Walking the Talk – How Should Policy Uphold Equity in Value Assessment?

Date: Wednesday, July 14, 2021
Time: 1:00 PM EDT

Broad commitments to improving health equity are laudable – and long-overdue. Without a policy and regulatory environment that incentivizes change, however, commitments alone cannot succeed in improving health equity or reducing disparities in access and outcomes.

Policymakers have the opportunity to affect real change, but in the decentralized, market-driven U.S. healthcare system, the path forward is far from clear. In particular, interest in formalizing the use of economic evaluations in coverage and reimbursement decisions is growing, presenting both a quandary and an opportunity.

What policy actions are needed to incentivize changes in the behavior of organizations and individuals that will reduce disparities – and what are the key decisions to target? What role should value assessments play in shaping the decisions that determine access and outcomes?

Jennifer Bright, MPA (Moderator)
Jennifer Bright, MPA (Moderator)Innovation and Value Initiative
Phylicia L. Woods, JD, MSW
Phylicia L. Woods, JD, MSWCancer Support Community
As Executive Director of Cancer Policy Institute at the Cancer Support Community, Phylicia Woods is responsible for legislative, regulatory, policy, and research priorities as well as operations, fundraising, and management. She previously served as Director of Federal Relations at the American Cancer Society Cancer Action Network; Counsel to Former U.S. Senator Claire McCaskill on U.S. Senate Homeland Security and Governmental Affairs Committee and Health Counsel on U.S. Senate Special Committee on Aging.
Jessica Brooks, MPM, PHR
Jessica Brooks, MPM, PHRPittsburgh Business Group on Health
In her role as CEO and Executive Director, Ms. Brooks is leading the effort to redefine and advance the discussion around health care value, access, and quality on behalf of employers. Investigating shortfalls within the health benefits ecosystem has led her to recognize the enormous potential in employer collaboration to make large-scale decisions and ultimately transform health care. Ms. Brooks is also the founder of US Health Desk.
Joshua M. Liao, MD, MSc, FACP
Joshua M. Liao, MD, MSc, FACPUniversity of Washington, School of Medicine
Dr. Liao is a board-certified internal medicine physician and national expert on payment and related delivery reform. He is an Associate Professor in the University of Washington School of Medicine, where he also directs the Value and Systems Science Lab, dedicated to improving health care by transforming ideas and data into actionable insight about how we finance, deliver, and make decisions about health care. He is also the Medical Director of Payment Strategy at UW Medicine.

View the Recorded Webinar

VIEW

Recent Events

IVI Model Scope on Major Depressive Disorder

Date: Monday, May 3, 2021
Time: 1:00 PM EDT

IVI launched the Major Depressive Disorder (MDD) initiative to build a flexible, open-source, and patient-centric model that will help inform the decision needs of multiple stakeholders in the health care system.

According to the National Alliance on Mental Illness, over 19 million adults had at least one MDD episode in the past year; the COVID-19 pandemic has only exacerbated the unmet need for depression treatment. Conventional cost-effectiveness models for assessing the value of MDD treatments typically do not prioritize factors and outcomes important to patients.

This webinar will cover the major points of the new model scope for the MDD initiative, and address the importance of a patient-centric model for MDD. Via a public comment period from April 12th to May 14th, stakeholders are invited to provide recommendations on the most important factors to build into the model.

Rick Chapman, PhD (Moderator)
Rick Chapman, PhD (Moderator)Innovation and Value Initiative
Jessica Kennedy
Jessica KennedyMental Health America
In her role as Chief of Staff at Mental Health America, Ms. Kennedy focuses on screening, workplace mental health, public education, digital marketing, mental health policy, and program management. She launched the organization’s online screening program in 2014, now the largest database of mental health screens worldwide.
Mohannad (Ned) Kusti, MD, MPH
Mohannad (Ned) Kusti, MD, MPHPivot Onsite-Innovations
A global physician executive and healthcare consultant, Dr. Kusti has unique expertise and experience related to corporate healthcare benefits. He is consulting for numerous employers in COVID-19 corporate management. Dr. Kusti is the Corporate Medical Director at Pivot Onsite-Innovations and also teaches occupational and environmental health sciences at West Virginia University.
Richard Xie, PhD
Richard Xie, PhDInnovation and Value Initiative
A health economist and HEOR Manager at the Innovation and Value Initiative, Dr. Xie has played a lead role in developing the IVI-Major Depressive Disorder Model Scope. He has a long track record of conducting HEOR studies to inform health policy design and valuation of pharmaceutical therapies.

View Recorded Webinar

VIEW

View Presentation Slides

Download

Principles for Good Value Assessment

Date: Thursday, February 25, 2021
Time: 2:00 PM EST

In December, IVI dubbed 2021 “the year of the patient”: advancing the conversation and practice of patient-centered value assessment in tangible ways. The patient voice is crucial in achieving the promise of value assessment to improve care, achieve better outcomes, and lower costs.

In this webinar, dialogue with IVI and patient advocates about patient-centricity in action and learn more about activities for the year ahead. IVI’s new Principles for Value Assessment in the U.S. was discussed, along with their practical application for patients, employers, and researchers.

Alan Balch, PhD
Alan Balch, PhDPatient Advocate Foundation
Dr. Balch is the Chief Executive Officer of the Patient Advocate Foundation (PAF) and the National Patient Advocate Foundation (NPAF). Dr. Balch is a member of IVI’s Patient Advisory Council.
Jennifer Bright, MPA
Jennifer Bright, MPAInnovation and Value Initiative
Ms. Bright is the Executive Director of the Innovation and Value Initiative. She brings over two decades of healthcare policy, issue management, patient advocacy and executive leadership to this position.

The full recorded webinar is now available for viewing.

VIEW

ISPOR-IVI Webinar Series

IVI and ISPOR collaborated, with the help from an expert advisory committee, to define and host a series of webinars highlighting key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series explored multiple viewpoints and focused on potential pathways for solutions in international and U.S.-focused value assessment and health technology assessment (VA/HTA).

To view all five sessions, visit our webinar archive here.